P

A

PRELAJ , Arsela

Last name: PRELAJ

First name: Arsela

2022 (v1)

Publication

Metadata-only

Prognostic scores including peripheral blood-derived inflammatory indices in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitors

Rebuzzi, Sara Elena Prelaj, Arsela Friedlaender, Alex

Peripheral blood inflammatory indices, like the neutrophil-to-lymphocyte ratio (NLR), may reflect the host's pro-inflammatory status and systemic immune response to cancer-related inflammation. We reviewed 22 combined prognostic scores based on peripheral blood-derived inflammatory indices for aNSCLC patients treated with single-agent or...

Uploaded on: February 4, 2024
2024 (v1)

Publication

Metadata-only

APOLLO 11 Project, Consortium in Advanced Lung Cancer Patients Treated With Innovative Therapies: Integration of Real-World Data and Translational Research

Prelaj, Arsela Ganzinelli, Monica Provenzano, Leonardo

Introduction: Despite several therapeutic efforts, lung cancer remains a highly lethal disease. Novel therapeutic approaches encompass immune-checkpoint inhibitors, targeted therapeutics and antibody-drug conjugates, with different results. Several studies have been aimed at identifying biomarkers able to predict benefit from these therapies...

Uploaded on: July 3, 2024